The discovery of systemic disease related to raised tissue and serum immunoglobulin G4 (IgG4) is changing diagnostic and therapeutic practice in many medical specialties. Orbital inflammation remains ...

They could be doing better, at least in Europe. Data from 14 centers revealed moderate adherence to treatment guidelines, partial adherence to follow-up assessment, and poor adherence to monitoring ...

SAN JUAN, Puerto Rico — A small but significant percentage of patients with Graves' disease show elevated plasma levels of immunoglobulin G4 (IgG4), suggesting the presence of a novel subtype of the ...

“[T]he identification of effective and well‐tolerated glucocorticoid‐sparing treatment options may allow for reduced glucocorticoid exposure in patients with IgG4‐ RD, with the subsequent potential to ...

Advances Amgen's Leadership in CD19 Directed, B-Cell Depletion Therapies for Serious Autoimmune Diseases Including NMOSD, IgG4-RD and gMG THOUSAND OAKS, Calif., April 3, 2025 /PRNewswire/ -- Amgen ...

Obexelimab Phase 3 INDIGO trial topline results in Immunoglobulin G4-Related Disease (IgG4-RD) expected around year-end 2025 ...

Anti-C1q antibodies were present among 74.3% of patients with immunoglobulin G4-related disease. Anti-C1q antibodies are highly prevalent among patients with immunoglobulin G4-related disease (IgG4-RD ...

In a recent study published in Science Immunology, researchers evaluated immunoglobulin G (IgG) responses to coronavirus disease 2019 (COVID-19) messenger ribonucleic acid (mRNA) vaccinations. Study: ...

People with muscle-specific kinase myasthenia gravis appear to have more active antibody responses in general, the study found. People with muscle-specific kinase (MuSK) myasthenia gravis (MG) have ...

WALTHAM, Mass., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Zenas BioPharma, Inc. (ZBIO), a clinical-stage global biopharmaceutical company committed to being a leader in the development and commercialization ...

In a recent focus piece published in Science Immunology, a researcher emphasized the need to reconsider messenger ribonucleic acid (mRNA) coronavirus disease 2019 (COVID-19) vaccination strategies in ...